Introduction {#Sec1}
============

Botanicals are present not only in the food chain but have also gained wide acceptance as nutritional supplements. Many botanicals are also reported to have medicinal capabilities and are part of organized practices in traditional medicine. In many cases, these botanicals have significant history of human usage and this perspective often supports safety assessments. For other botanicals, this human usage perspective is neither available nor adequate and, in those situations, additional data are required to support safety assessments.

An alternative to safety testing of the whole extract is to semi-quantitatively determine and then assess the safety of the botanical's chemical constituents. This is one of the approaches recommended \[[@CR1]\] for more accurate safety assessment of botanicals used in foods. The literature is replete with evidence of the improving ability of various analytical technologies to characterize complex botanical mixtures. However, quantitating the individual chemical constituents, in the absence of authentic reference standards, remains problematic.

High-performance liquid chromatography (HPLC), combined with both UV (ultraviolet) detection and high-resolution mass spectrometry (HRMS), is a well-known platform for the identification of analytes in complex mixtures. Neither detector is particularly well-suited for quantitation of various molecules across or often even within compound classes, in the absence of authentic reference standards. The UV detector is dependent on the presence of a chromophore in the molecules of interest and their ability to absorb UV (and visible) light. This can obviously vary from structure-to-structure and in particular across compound classes. The ionization/volatilization interface of an HPLC/MS system is even more variable and is sensitive to even small changes in molecular structure. Therefore, while useful for identification of unknowns, neither of these detectors is suitable for providing quantitation data for a complex mixture containing constituents for which reference standards are not available. This requires a general detector where signal is directly proportional to analyte mass, in much the same way that flame ionization detection (FID) is utilized when coupled with gas chromatography \[[@CR2]\]. Quantitation of natural product constituents has been demonstrated with quantitative nuclear magnetic resonance \[[@CR3]\]; however, the approach is not suitable for comprehensive quantitation of complex mixtures containing many analytes with similar structural features.

A charged aerosol detector (CAD) is suitable for detection of semi-volatile and non-volatile analytes (boiling point \> 350 °C) separated by HPLC. This detector provides signal that corresponds to the mass of each analyte, irrespective of chemical structure \[[@CR4]\].

We have assembled an instrumental configuration to separate complex botanical mixtures using ultra-high-performance liquid chromatography (UHPLC) followed by UV, CAD, and HRMS detection. This allows direct correlation between identification and relative quantitation of chemical constituents in complex mixtures. The experiment has been optimized specifically to produce data that is then utilized in threshold of toxicological concern \[[@CR1]\] and other in-silico safety assessments, as well as quality evaluations. A fairly well-characterized botanical, *Ginkgo biloba*, was chosen to develop and illustrate this approach \[[@CR5]--[@CR10]\].

Materials and methods {#Sec2}
=====================

Sample preparation {#Sec3}
------------------

The *Ginkgo biloba* leaf extract used was Spectrum Ginkgo Standardized Extract (Lot \# YT0930, Spectrum Chemical, 769 Jersey Ave., New Brunswick, NJ 08901-3605). The extract, a dry powder, was stored at room temperature, the recommended use condition, for the duration of the study (several months). The definition of "standardized extract" is flavonoid glycosides \> 24% and triterpene lactones \> 6%. The methods the vendor used to support these claims is not known to us; however, these numbers correlate with our results. The extract powder was dissolved in 70/30 ethanol/water to 20 mg/mL, vortexed for 30 min, and then filtered through a 0.2 μm PTFE membrane.

Reference standards {#Sec4}
-------------------

The standards were reference materials (not certified reference materials) with purities greater than or equal to 95%. Standards were prepared at 25 ng/μL in 70% ethanol/30% water. In all cases, the accurate MS and MS/MS data supported that the standards were as labeled. The standards were obtained from several sources. Chromadex (Irvine, CA): Xanthurenic acid, Isorhamnetin, Isoquercetin, Kaempferol rutinoside, Isorhamnetin glucoside, Genistein, Kaempferol. Sigma-Aldrich Corp. (St. Louis, MO): [l]{.smallcaps}-Proline, [l]{.smallcaps}-Valine, Choline, Mannitol, [l]{.smallcaps}-Tryptophan, Caffeine, Catechin, Gallocatechin, Vanillic Acid, Esculetin, Ginkgolide A, Ginkgolide B, Ginkgolide C, Ginkgolide J, Rutin, Quercetin, Bilobalide, Quercitrin, Isorhamnetin rutinoside, Soyasaponin I, Ginkgolic Acid (C13:0), Ginkgolic Acid (C15:1); MP Biomedicals (Solon, OH): Protocatechuic acid, Myricetin; Alfa Aesar Tewksbury, MA)---Salicylic acid, Quinic acid; TCI (Portland OR)---Trigonelline.

Instrumental conditions {#Sec5}
-----------------------

The instrumental configuration for this method is shown in Fig. [1](#Fig1){ref-type="fig"}. Essential experimental details are shown below, with additional details provided in the Electronic Supplementary Material (ESM) Table [S2](#MOESM1){ref-type="media"}.Fig. 1Schematic of the instrumental configuration for UHPLC/UV/CAD/Q-TOF MS experiments

### Chromatography {#FPar1}

An Agilent Technologies (5301 Stevens Creek Blvd Santa Clara, CA 95051 USA) 1290 Infinity chromatograph (UV photodiode array detector (PDA)) was used for the UHPLC separations, with a Waters (34 Maple Street, Milford, MA 01757 USA) Acquity BEH C~18~ (2.1 × 150 mm, 1.7 μm particles) column. Injections used 3 μL of sample extracts. The separation used mobile phase A (water with 0.1% formic acid (FA)) and B (acetonitrile with 0.085% FA) with a flow rate of 0.4 mL/min. The gradient consisted of a 5-min hold at 2% A, followed by a linear ramp from 2% A to 100% A, at 1%/min, for a total acquisition time of 125 min.

### Mass spectrometry {#FPar2}

The high-resolution mass spectrometry detection was performed using an Agilent 6540 UHD Accurate Mass quadrupole-time-of-flight (Q-TOF) system, with MassHunter software (version B.04.00). Experiments were conducted in positive and negative ion modes, using the Agilent Jetstream**®** electrospray ionization (ESI) and atmospheric pressure chemical ionization (APCI) sources. Mass spectrometry data was collected from *m*/*z* 50--3200 at 5 Hz. Tandem mass spectrometry (MS/MS) experiments, specifically product ion scans, were performed on \[M + H\]^+^, \[M − H\]^−^ or other precursor ions.

### Quantitation detector {#FPar3}

A charged aerosol detector from ESA (now part of Thermo Scientific, 81 Wyman Street, Waltham, MA 02451 USA) was used to quantitate the analytes. This detector signal output was connected to the mass spectrometer data system through an Agilent 35900E interface (analog-to-digital converter). Additionally, the gas used was N~2~ at 35 PSI, with a detector range of 100 pA and a data collection rate of 10 Hz.

### Inverse gradient {#FPar4}

A separate HPLC pump was utilized to deliver the inverse gradient to the flowing stream, post-column (see Fig. [1](#Fig1){ref-type="fig"}). A Shimadzu (1, Nishinokyo-Kuwabaracho, Nakagyo-ku, Kyoto 604-8511, Japan) controller (SCL-10A) and pumps (LC-10AD), with a Gilson (3000 Parmenter Street, Middleton, WI 53562 USA) 811C Dynamic mixer (65 μL), was used for this purpose, triggered by a contact closure connection to the mass spectrometer data system, via the Agilent UV detector.

Results and discussion {#Sec6}
======================

The instrumental configuration shown in Fig. [1](#Fig1){ref-type="fig"} was intended to optimize the separation of complex mixtures and gather information from three separate detectors in order to most easily correlate identifications made by the mass spectrometer with quantitation by the CAD. Separate experiments using the mass spectrometer and CAD are problematic due to the need to very carefully correlate the presence of multiple analytes, observed by MS, within CAD peaks and more generally by the complex nature of these mixtures. In practice, the analysis of a sample was performed multiple times to gather different mass spectrometry data, positive and negative ion data, compare ESI and APCI volatilization/ionization modes, and then to perform MS/MS experiments to aid identifications on analytes of interest, but in each case by carefully correlating UV, MS, and CAD data. This approach allows the collection of orthogonal data sets on the sample. These are chromatographic retention, UV spectra, quantitative CAD signals, and a variety of MS and MS/MS spectra. There were a number of experimental considerations that facilitated data generation intended to support the in-silico safety assessments.

Chromatography {#Sec7}
--------------

The primary considerations in chromatographic method development are to separate the individual constituents to the extent possible and elute all the analytes present in the sample. Furthermore, sample numbers in these experiments are low and data acquisition consumes less time than data mining and interpretation. Therefore, longer empirically developed chromatographic separations, such as the 125 min one shown here, that pull similar analytes apart and ideally present them to the detectors individually are the objective. The separation here started with very low organic content (2%) to 100% organic, with a slow gradient, in order to elute a broad range of analytes (highly polar to non-polar). In practice, it has, in our experience, never been possible to fully separate the many analytes in a botanical extract; however, optimizing the separation of the overall mixture does facilitate data interpretation and quantitation. UHPLC is preferred whenever possible, over HPLC, due to its superior resolving capability, but there are cases when the preferred stationary phase may be available only in an HPLC format (e.g., for botanicals with significant percentages of relevant highly polar, early eluting analytes). The highly polar analytes that are poorly separated in the first 5 min of the example analysis here are of less interest or concern with respect to the safety assessment; therefore, chromatographic conditions more suitable to medium polar analytes were used.

Inverse gradient {#Sec8}
----------------

This inverse gradient addition mirrored the UHPLC gradient such that the CAD (and mass spectrometer) were presented with a consistent \~50/50 organic/water mixture. This served to eliminate the known response bias of the CAD (less responsive to high aqueous content) and maintained a consistent response across the entire analysis \[[@CR11], [@CR12]\]. In our hands, the intensity difference between the same analyte detected via flow injection/CAD analysis in 100% aqueous and then in 100% organic varied by as much as sixfold (data not shown). Furthermore, the addition of organic content by this inverse gradient arrangement served to increase both the CAD and MS response for the majority of polar analytes that eluted in the relatively early, high aqueous portion of the separation. The inverse gradient increased the CAD signal by a factor of two or three in the majority of the chromatogram (Fig. [2](#Fig2){ref-type="fig"}). More importantly, from a chromatographic perspective, the inverse gradient did not have an adverse effect on peak shape, as noted by comparing peak asymmetry and tailing factors (Fig. [3](#Fig3){ref-type="fig"}).Fig. 2Post-column addition of gradient running inverse to the eluent consistently presented a constant \~50:50 acetonitrile:water mixture to the charged aerosol detector, reducing the known bias of CAD response relative to organic composition. Partial chromatograms shown, illustrating improvements in the early (high aqueous) portion of the analysis (note peak height v. signal intensity on y-axis). Total run time was 125 minFig. 3Illustration that the addition of the inverse gradient did not appreciably broaden the chromatographic peaks, shown here for Bilobilide. The USP system suitability factors were used: Peak asymmetry factor *A*~f~ = b~10%\ h~ /a~10%\ h,~ Tailing factor *T* = (a~5%h~ + b~5%h~)/2a~5%h~

Charged aerosol detection {#Sec9}
-------------------------

With the ultimate objective, in this work, of a safety assessment of the constituents at or above the threshold of toxicological concern, attempts to identify analytes, with the other detectors, were keyed off CAD peaks observed (quantitative data). To maximize the dynamic range of the experiment and quantitate as many analytes as possible, the amount of sample injected on-column can be adjusted such that the most abundant CAD peak is just short of saturation. Then, CAD peaks as low as 0.05% of the total CAD signal can be observed, with a signal-to-noise ratio of at least 3:1. Analytes not observed by CAD but identified by MS can then be indicated as \< 0.05% of the mass of the sample, in this case. Analytes were quantitated based upon percentage of the overall CAD signal. While this is not the most accurate means of quantitation and could be called semi- or relative-quantitation, it is possible in the absence of standards of each analyte and is adequate for the purposes of the inherently conservative threshold of toxicological concern assessment. Preliminary comparison of the CAD quantitation to quantitation with standards of compounds used for positive identifications suggests CAD accuracy is no worse than a factor of 2, again, adequate for these purposes. That said, an approach using response factors with CAD signal promises significantly better accuracy. Investigations in progress will define accuracy and precision more completely, in a future report. Alternately, evaporative light scattering detection (ELSD) could be used in a similar manner; however, in our hands and in literature reports \[[@CR13], [@CR14]\], this technology has less sensitivity than CAD.

High-resolution mass spectrometry {#Sec10}
---------------------------------

HRMS is vital to the confident identification of botanical constituents, particularly in the absence of standards. HRMS can be utilized to quickly assign molecular formula. Searching a formula (e.g., with SciFinder) in the context of a particular botanical often provides feasible results \[[@CR15]\]. MS/MS experimentation with accurate mass results provides structural clues than can support these search results, be compared against fragmentation of other molecules within the same class, or even provide identification when compared to databases such as mzCloud \[[@CR16]\].

Characterization approach {#Sec11}
-------------------------

The identifications reported here were made with the following important considerations.No attempt to fully characterize or exhaustively identify all the components of the extract was made. Rather, identification of the compounds that gave a detectable CAD response in these particular analyses was attempted. The amount of material analyzed was adjusted to provide CAD signals down to the threshold of toxicological concern \[[@CR17]\]. Although the mass spectrometer could often detect analytes below this level, these constituents were not considered because the in silico safety assessment was the goal of this work.It is possible that organic components of the samples did not elute from the column or respond to either UV or CAD detection, electrospray, or atmospheric chemical ionization and were therefore not observed. Volatile analytes in particular would not be expected to be detected using this approach; however, in this case, the sample was dried powder and where therefore unlikely to contain a significant amount of volatile material.The isotope fitting "score" (shown in ESM Table [S1](#MOESM1){ref-type="media"}) is a software calculation (called MFG Score in the software), from 0 to 100, that compares the theoretical data for the given empirical formula to the experimental data. The score calculation factors in comparison of mass accuracy, abundance fit of naturally occurring isotope ratio (the monoisotopic peak A, compared to A + 1 and A + 2), and exact mass spacing of *m*/*z* peaks in the isotopic envelope. A score above 90 is considered confident and in most cases the assigned molecular formula had the highest score of the possible formulae. In some instances, lower scores or mass accuracies do not indicate an incorrect assignment, but were caused by interferences from chemical background, co-eluting analytes, low level signal, or experimental variance. A sense of how well the mass accuracy and scores work can be obtained from the values determined for those analytes that were confirmed by authentic standard comparison (i.e., known to be correct).In many cases, authentic standards of the compounds were also analyzed, when available, and this allowed definitive identification of these compounds. In all other cases, the proposed identifications were made with variable confidence (dimensioned in the table), based upon the data, expectations of what should be present from the literature and comparison to mass spectral data of authentic standards of similar compounds.

Test case results {#Sec12}
-----------------

The chromatographic results from the analysis of the standardized *Ginkgo biloba* extract are shown in Fig. [4](#Fig4){ref-type="fig"}. Partial chromatograms are shown to best illustrate the majority of analytes observed by the three detectors (UV, CAD, HRMS), and two MS ionization/volatilization modes (electrospray (ESI) and atmospheric chemical ionization (APCI)). CAD, UV, and MS results from only one ionization/volatilization mode could be obtained in a single experiment. Separate analyses were required to obtain data in additional MS modes or to obtain MS/MS information (data-dependent analysis not used here).Fig. 4Partial chromatograms from the UHPLC/UV/CAD/Q-TOF-MS analysis of the Ginkgo extract showing the majority of analytes from the 125-min analysis. Note peak numbers on the CAD chromatogram. Results in Table [1](#Tab1){ref-type="table"} are organized by peak number

Relative amounts of 83 peaks, down to 0.05% of the total CAD signal, were obtained by CAD, for this botanical extract. UHPLC resolved isomers of known analytes and presented fewer coeluting peaks to the detectors than was possible via HPLC. The mass spectrometer was found to be more sensitive than the CAD, as expected. Indications of a least 50 lower level analytes not seen by CAD (\< 0.05% of total signal each) or coeluting in CAD peaks as minor signals observed by mass spectrometery were noted but not characterized or interpreted. Quantitation and identification of these lower level analytes were not pursued as they fell below the level of interest (i.e., threshold of toxicological concern). Data were collected in the APCI mode in case some analytes did not respond via ESI; however, no unique data were obtained by APCI, even for late-eluting, presumably non-polar analytes (peaks 79, 82, and 83). For the purposes of this preliminary investigation, the broad hump in the chromatogram that the majority of the peaks are sitting on, which was not observed in the blank, has not been factored into consideration. This is believed to have been caused by chromatographically unresolved tannins \[[@CR18]\]. The presumed tannin hump is not observed in the mass spectrometry chromatograms shown in Fig. [4](#Fig4){ref-type="fig"} as these are from lower amount injections required to keep the other analytes on scale.

The results of the characterizations of the 83 CAD peaks are shown in Table [1](#Tab1){ref-type="table"}. The identifications are presented in elution order and peak numbers correspond to those shown in the CAD chromatogram in Fig. [4](#Fig4){ref-type="fig"}. In cases where an analyte has been identified with high confidence (i.e., matched to an authentic standard), the name and chemical abstracts service (CAS) number are provided (from the material containers). CAS numbers for other known compounds were obtained from SciFinder, recognizing that these numbers can vary based upon salt form, synthetic source, and that some analytes have multiple CAS numbers. Additionally, comments are made for each peak's identification to indicate the level of confidence in the proposed structure and other information that may be of relevance to a safety assessment (e.g., the presence of specific functional groups) \[[@CR17]\]. For the purposes of a safety assessment using threshold of toxicological concern, which focuses on comparing functional groups and substructure of molecules, absolute identification of a molecule and its specific connectivity are not essential. An identification of a molecule that includes its functionalities, but not all the connectivity, is still useful. Even a partial identification, such as the presence of glycosylation, has value when the identified substructure is considered detoxifying.Table 1Proposed identifications of the 83 CAD peaks observed during the analysis of the Spectrum Ginkgo extractCAD Peak numberProposed ID (CAS \#)Molecular FormulaComments1MagnesiumMg^2+^Magnesium clusters with acetonitrile and formic acid in positive ion mode and Magnesium clusters with formic acid in negative ion mode. Example here is \[MgFm+2ACN\]^+^. MgFm2 repeat has a mass difference of 113.98043. In negative ion, example is \[Mg+3Fm\]^-^. Isotope pattern consistent with Mg.2Choline (67-48-1)C~5~H~14~N~1~O~1~RT, UV and MS/MS spectra consistent with authentic standard.3Trigonelline (6138-41-6)C~7~H~7~N~1~O~2~RT, UV and MS/MS spectra consistent with authentic standard.L-Proline (147-85-3)C~5~H~9~N~1~O~2~RT, UV and MS/MS spectra consistent with authentic standard.L-Valine (72-18-4)C~5~H~11~N~1~O~2~RT, UV and MS/MS spectra consistent with authentic standard.Mannitol (69-65-8)C~6~H~14~O~6~RT, UV and MS/MS spectra consistent with authentic standard.Quinic Acid (77-95-2)C~7~H~12~O~6~RT, UV and MS/MS spectra consistent with authentic standard.4Ginkgotoxin-5-O-glucoside (323579-25-5)C~15~H~23~N~1~O~8~MS/MS indicates hexose and is consistent with structure \[[@CR20]\].UnknownC~7~H~12~O~5~Unknown, but probably similar to Quinic acid (less oxygen).5Protocatechuic Acid (99-50-3)C~7~H~6~O~4~RT, UV and MS/MS spectra consistent with authentic standard.6Xanthurenic Acid (59-00-7)C~10~H~7~N~1~O~4~RT, UV and MS/MS spectra consistent with authentic standard.7UnknownC~16~H~24~O~9~Observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode.L-Tryptophan (73-22-3)C~11~H~12~N~2~O~2~RT, UV and MS/MS spectra consistent with authentic standard.8Caffeine (58-08-2)C~8~H~10~N~4~O~2~RT, UV and MS/MS spectra consistent with authentic standard.9Gallocatechin (3371-27-5)C~15~H~14~O~7~RT, UV and MS/MS spectra consistent with authentic standard.Hydroxy-benzaldehydeC~7~H~6~O~2~MS/MS spectrum suggests Hydroxybenzaldehyde10Vanillic Acid (121-34-6)C~8~H~8~O~4~RT, UV and MS/MS spectra consistent with authentic standard.Esculetin (305-01-1)C~9~H~6~O~4~RT, UV and MS/MS spectra consistent with authentic standard.Catechin (7295-85-4)C~15~H~14~O~6~RT, UV and MS/MS spectra consistent with authentic standard.Salicylic Acid (69-72-7)C~7~H~6~O~3~RT, UV and MS/MS spectra consistent with authentic standard.Quercetin with 2 glucose and 1 rhamnoseC~39~H~50~O~25~MS/MS shows losses of glucose and rhamnose.11UnknownC~19~H~28~O~11~Observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode. MS/MS indicates hexose present.12UnknownC~32~H~44~O~17~Observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode. MS/MS indicates hexose present.13Kaempferol tetraglycoside (2 glucose and 2 rhamnose)C~39~H~50~O~24~Proposed compound from MS/MS data. Connectivity unknown.14Glucopyranosyl rutinC~33~H~40~O~21~Proposed compound based on MS/MS data.Astilbin (29838-67-3)C~21~H~22~O~11~Proposed based on MS/MS data.15Kaempferol rhamnosyl glucosideC~27~H~30~O~15~Proposed compound based on MS/MS data and literature \[[@CR21]\]. Observed as \[M+ Formate\]^-^ in negative ion mode.16Bilobalide (33570-04-6)C~15~H~18~O~8~RT, UV and MS/MS spectra consistent with authentic standard.17Quercetin rhamnosyl rutinoside isomerC~33~H~40~O~20~Proposed compound based on MS/MS and literature \[[@CR21]\].18Kaempferol di-rhamnosyl- glucosideC~33~H~40~O~19~Proposed structure based on MS/MS and literature \[[@CR21]\].Isorhamnetin di-glucosyl- rhamnosideC~34~H~42~O~21~Proposed structure based on MS/MS.19UnknownC~15~H~20~O~9~This unknown one of several analytes within this peak. \*20Quercetin rhamnosyl rutinoside isomerC~33~H~40~O~20~Proposed compound based on MS/MS.UnknownC~27~H~30~O~15~MS/MS shows some indication of a possible kaempferol rutinoside.Kaempferol glucosyl-coumaryl-glucosyl rhamnosideC~48~H~56~O~27~MS/MS fragments indicate loss of coumaryl, rhamnose and hexose.21Myricetin rutinosideC~27~H~30~O~17~Proposed structure based on MS/MS and literature \[[@CR22]\].Bilobalide isomerC~15~H~18~O~8~Probable isomer of Peak 16.22Quercetin rhamnosyl rutinoside isomerC~33~H~40~O~20~Proposed compound based on MS/MS and literature \[[@CR21]\].23Quercetin rhamnosyl rutinoside isomerC~33~H~40~O~20~Proposed compound based on MS/MS and literature \[[@CR21]\].24Rutin isomerC~27~H~30~O~16~Proposed compound based on MS/MS and literature \[[@CR22]\].25Ginkgolide J (107438-79-9)C~20~H~24~O~10~RT, UV and MS/MS spectra consistent with authentic standard. Observed as \[M+ Formate\]^-^ in negative ion mode.26Quercetin glucosyl-coumarylglucosyl rhamnosideC~42~H~46~O~23~Proposed structure based on MS/MS and literature \[[@CR22]\].27Kaempferol di-rhamnosyl- glucosideC~33~H~40~O~19~Proposed structure based on MS/MS. Kaempferol fragment ion observed in MS/MS \[[@CR21]\].28Rutin (153-18-4)C~27~H~30~O~16~RT, UV and MS/MS spectra consistent with authentic standard. Possible second isomer nearly coeluting with Rutin.Ginkgolide C (15291-76-6)C~20~H~24~O~11~RT, UV and MS/MS spectra consistent with authentic standard. Relative amounts of these two coeluting compounds probably not different by more than a factor of two.29Isoquercetin (482-35-9)C~21~H~20~O~12~RT, UV and MS/MS spectra consistent with authentic standard.Laricitrin rutinoside IsomerC~28~H~32~O~17~Proposed structure based on MS/MS and literature \[[@CR22]\]. Isorhamnetin fragment observed in MS/MS spectrum.30Laricitrin rutinoside IsomerC~28~H~32~O~17~Proposed structure based on MS source fragments, literature \[[@CR22]\].31Kaempferol glucosylcoumarylglucosyl rhamnosideC~42~H~46~O~22~Proposed structure based on MS/MS and literature \[[@CR22]\].32Quercetin glucosylcoumarylglucosyl rhamnosideC~42~H~46~O~23~Proposed structure based on MS/MS and literature \[[@CR22]\].UnknownC~26~H~34~O~11~Observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode. MS/MS indicates hexose present.33Isomer of RutinC~27~H~30~O~16~Structure similar to Rutin based on similar MS/MS fragment ions observed from Rutin. MS/MS spectrum shows aglycone quercetin fragment.34Kaempferol rutinoside (17650-84-9)C~27~H~30~O~15~RT, UV and MS/MS spectra consistent with authentic standard.35Quercitrin (522-12-3)C~21~H~20~O~11~RT, UV and MS/MS spectra consistent with authentic standard.36Isorhamnetin rutinoside (604-80-8)C~28~H~32~O~16~RT, UV and MS/MS spectra consistent with authentic standard.37Limocitrin rutinoside (489-33-8)C~29~H~34~O~17~Possibly Limocitrin (489-33-8) rutinoside. MS/MS indicates rutinoside and limocitrin aglycone.Kaempferol glucoside isomerC~21~H~20~O~11~MS/MS indicates presence of hexose.Myricetin (529-44-2)C~15~H~10~O~8~RT, UV and MS/MS spectra consistent with authentic standard.UnknownC~26~H~46~O~14~MS/MS indicates hexose present.38Genistein rutinosideC~27~H~30~O~14~MS/MS suggests genistein aglycone, hexose and rhamnose (cannot rule out apigenin as the aglycone). This appears to be the more abundant of the two similar coeluting compounds.Isorhamnetin glucoside (5041-82-7)C~22~H~22~O~12~RT, UV and MS/MS spectra consistent with authentic standard.39UnknownC~28~H~36~O~13~Observed as \[M+NH~4~\]^+^ in positive ion mode. MS/MS indicates presence of hexose.40Isomer of Kaempferol rutinoside (17650-84-9)C~27~H~30~O~15~MS/MS suggests hexose and kaempferol aglycone.Kaempferol rutinoside substructureC~43~H~46~O~22~MS/MS data confirms substructure of kaempferol rutinoside. Remainder of formula corresponds to epigallocatechin methyl ether.41Isomer of Quercitrin (522-12-3)C~21~H~20~O~11~MS/MS confirms quercetin aglycone and rhamnose.UnknownC~26~H~34~O~10~Observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode.42UnknownC~32~H~42~O~14~This empirical formula is confident, but MS/MS does not clarify structure.43Kaempferol rhamnosideC~21~H~20~O~10~MS/MS confirms kaempferol aglycone and rhamnose.UnknownC~20~H~36~O~11~Observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode. MS/MS confirms hexose.44Ginkgolide IsomerC~20~H~24~O~10~Possibly Ginkgolide M. Also observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode. MS/MS spectrum similar to that of isobaric Ginkgolide B (Peak 46)45Quercetin coumarylglucosyl rhamnoside isomerC~36~H~36~O~18~Assignment based on literature \[[@CR22]\] and MS/MS in negative ion mode. MS/MS suggests coumaryl group, rutinoside and quercetin.46Ginkgolide A (15291-75-5)C~20~H~24~O~9~RT, UV and MS/MS spectra consistent with authentic standard. Also observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode.Ginkgolide B (15291-77-7)C~20~H~24~O~10~RT, UV and MS/MS spectra consistent with authentic standard. Also observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode.47UnknownC~21~H~30~O~9~Observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode. MS/MS indicates hexose.48UnknownC~19~H~22~O~5~MS/MS shows facile loss of formic acid.49Quercetin (117-39-5)C~15~H~10~O~7~RT, UV and MS/MS spectra consistent with authentic standard.50Kaempferol coumarylglucosyl rhamnoside isomerC~36~H~36~O~17~MS/MS confirms coumaryl, rhamnosyl hexosyl and kaempferol aglycone. Assignment also based on literature \[[@CR22]\].51Quercetin coumarylglucosyl rhamnoside isomerC~36~H~36~O~18~MS/MS confirms coumaryl, rhamnosyl hexosyl and quercetin aglycone. Assignment also based on literature \[[@CR22]\].52Kaempferol-quercetin coumarylglucosyl rhamnoside isomerC~72~H~72~O~35~Appears to be chromatographically distinct dimer of MW = 740 and MW = 756 compound (Peaks 50 and 51). Observe doubly charged ion in both negative and positive ion modes. MS/MS confirms kaempferol and quercetin aglycones, rhamnose, glucose53UnknownC~21~H~34~O~9~Proposed elemental formula based on negative ion data. MS/MS indicates hexose.54Kaempferol-quercetin coumarylglucosyl rhamnoside isomerC~72~H~72~O~35~Appears to be chromatographically distinct dimer of MW = 740 and MW = 756 compound (Peaks 50 and 51). Observe doubly charged ion in both negative and positive ion modes. MS/MS confirms kaempferol and quercetin aglycones, rhamnose, glucose55Kaempferol-quercetin coumarylglucosyl rhamnoside isomerC~72~H~72~O~35~Appears to be chromatographically distinct dimer of MW = 740 and MW = 756 compound (Peaks 50 and 51). Observe doubly charged ion in both negative and positive ion modes. MS/MS confirms kaempferol and quercetin aglycones, rhamnose, glucose56Kaempferol coumarylglucosyl rhamnoside isomer dimerC~72~H~72~O~34~Appears to be chromatographically distinct dimer of MW = 740 (Peak 50). Observe doubly charged ion in both negative and positive ion modes. MS/MS confirms kaempferol aglycone, rhamnose, hexose.57Kaempferol coumarylglucosyl rhamnoside isomerC~36~H~36~O~17~MS/MS confirms coumaryl, rhamnosyl hexosyl and kaempferol aglycone. Assignment also based on literature \[[@CR22]\].58Genistein (446-72-0)C~15~H~10~O~5~RT, UV and MS/MS spectra consistent with authentic standard.59Kaempferol coumarylglucosyl rhamnoside isomer dimerC~72~H~72~O~34~Appears to be chromatographically distinct dimer of MW = 740 (Peak 50). Observe doubly charged ion in both negative and positive ion modes. MS/MS confirms kaempferol aglycone, rhamnose, hexose.60Kaempferol (520-18-3)C~15~H~10~O~6~RT, UV and MS/MS spectra consistent with authentic standard.61Kaempferol coumarylglucosyl rhamnoside isomer dimerC~72~H~72~O~34~Chromatographically distinct dimer of MW = 740 (Peak 50). Observe doubly charged ion in both negative and positive ion modes. MS/MS confirms kaempferol aglycone, rhamnose, hexose.62Isorhamnetin (480-19-3)C~16~H~12~O~7~RT, UV and MS/MS spectra consistent with authentic standard.Kaempferol coumarylglucosyl rhamnoside isomer dimerC~72~H~72~O~34~Appears to be chromatographically distinct dimer of MW = 740 (Peak 50). Observe doubly charged ion in both negative and positive ion modes. MS/MS confirms kaempferol aglycone, rhamnose, hexose.UnknownC~21~H~32~O~8~Observed as \[M+NH~4~\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode.63UnknownC~16~H~32~O~4~Water loss fragment in positive ion mode suggest hydroxylated C16 chain acid.64UnknownC~48~H~76~O~18~Observe \[M+NH4\]^+^ in positive ion mode. DBE = 11. Appears to be triterpenoid saponin related structure. Possibly Dehydrosoyasaponin I.65UnknownC~15~H~22~O~3~MS/MS response too weak. No MS/MS fragments.66(Z)-Alpha-Atlantone (56192-70-2)C~15~H~22~O~1~Proposed compound based on literature references and consistent with MS/MS spectrum \[[@CR22]\].UnknownC~47~H~74~O~17~Observed as \[M+NH~4~\]^+^ in positive ion mode. Appears to be triterpenoid saponin related structure.67UnknownC~21~H~40~O~7~Also observed \[M+Na\]^+^ and \[M+NH~4~\]^+^ in positive ion mode and observed \[M+ Formate\]^-^ in negative ion mode.68Soyasaponin I (51330-27-9)C~48~H~78~O~18~RT, UV and MS/MS spectra consistent with authentic standard.69UnknownC~42~H~68~O~14~Similar structure to Peak 68 based on MS/MS. Appears to be triterpenoid saponin related structure.70UnknownC~42~H~68~O~14~Similar structure to Peak 69 based on MS/MS. Appears to be triterpenoid saponin related structure.71UnknownC~48~H~78~O~17~Observe \[M+NH4\]^+^ in positive ion mode. DBE = 10. Appears to be triterpenoid saponin related structure.72Trihydroxy-octadecenoic acidC~18~H~34~O~5~MS/MS clearly suggests presence of acetate and three aliphatic hydroxyl groups. Position of hydroxyl groups and double bond unknown.73UnknownC~42~H~68~O~13~Observe \[M+NH4\]^+^ in positive ion mode. Appears to be triterpenoid saponin related structure.74UnknownC~25~H~40~O~5~MS/MS suggests coumaryl group and dihydroxy aliphatic C16 acid.75UnknownC~33~H~56~O~14~Observe \[M+NH4\]^+^ in positive ion mode and \[M+ Formate\]^-^ in negative ion mode.76UnknownC~18~H~30~O~2~MS/MS suggests dihydroxy- aliphatic C18 chain.77UnknownC~30~H~48~O~1~Possible triterpene compound with single hydroxyl group. Very weak. MS/MS signal.78UnknownC~18~H~32~O~2~Low Score caused by mass interferences and low signal. Signal too weak for MS/MS. Possibly Linoleic acid.79UnknownUnknownNo discernable MS signal obtained for CAD peak.80Ginkgolic Acid (C13:0)\
(20261-38-5)C~20~H~32~O~3~RT, UV and MS/MS spectra consistent with authentic standard.81Ginkgolic Acid (C15:1)\
(22190-60-7)C~22~H~34~O~3~RT, UV and MS/MS spectra consistent with authentic standard.82UnknownUnknownNo discernable MS signal obtained for CAD peak.83UnknownUnknownNo discernable MS signal obtained for CAD peak.\*Mass Spectra from these CAD peaks also contained other lower level signals that indicate the presence of other analytes not reported

An expanded version of Table [1](#Tab1){ref-type="table"} is shown in ESM Table [S1](#MOESM1){ref-type="media"}. This also contains the MS ionization mode data for each analyte. Some analytes were observed by both negative and positive ion MS. The mass accuracy in parts-per-million (ppm) is listed along with the score (comparison of experimental to theoretical mass accuracy and isotope fitting). In each case, the percentage of a peak's signal relative to the total CAD signal obtained from the analysis is listed. When known, the structures of the analytes are also shown in ESM Table [S1](#MOESM1){ref-type="media"}. In some cases, connectivity of groups could not be determined and Markush or parenthetical structures are shown, indicating known functional groups with unknown connectivity. Isomeric functional groups such as glucosides and galactosides could not be differentiated by this approach.

Some CAD peaks clearly contained more than one analyte. Usually, this was readily ascertained by comparing accurate (narrow) mass chromatograms, from signals observed in the summed mass spectrum, as shown in Fig. [5](#Fig5){ref-type="fig"}. This figure illustrates how the much faster data acquisition rate, effectively narrow detection window and specificity of TOF-HRMS, relative to the universal CAD, allowed confirmation of individual analytes. Other CAD peaks, indicated by "\*" in the table, contained low-levels of other signals, observed in corresponding mass spectra, indicating the presence of multiple analytes. Based upon their relatively low MS signals, these were presumed to be present below the levels of interest, with respect to a threshold of toxicological concern safety evaluation.Fig. 5Comparison of mass chromatograms of analytes contained within CAD peak 37. Although the CAD cannot resolve these analytes, narrow mass chromatograms, labeled with nominal mass, from the high-resolution mass spectrometer clearly illustrate the presence of four distinct analytes, as opposed to multiple signals (fragments or adducts) from one compound

No identification or useful characterization, from a safety assessment perspective, was obtained for about 10% of the total CAD signal. However, the data also indicate that no single unknown component exists above a level of 1.2% of the total CAD signal. For the purposes of a safety assessment such as threshold of toxicological concern, this would mean an unknown 1.2% constituent would be assigned the most conservative toxicity level for the overall material consideration.

Additional constituent information could have been obtained with this Gingko example, with further experimentation; however, from a safety standpoint, this was unnecessary. For instance, in some cases, MS/MS experiments were not performed to assist identifications (low level analytes or secondary experiments suggested after data interpretation). With additional effort, it is clear that further identifications could have been made, increased confidence on some identifications would be possible and perhaps improved specificity for some characterizations could be reported.

However, there would be a diminishing return on effort investment fairly quickly considering the level of data required for the safety assessment was largely met. This factor can be expected for each botanical characterization, by this or any other approach, and consideration when enough information has been gathered will be inherent to each project. This preliminary investigation was not designed to correlate quantitative CAD data to more rigorous quantitation using available authentic standards. Rather, the authentic standards were utilized for qualitative confirmation and were assayed at only one level. Future efforts will be designed for such a comparison, particularly at the CAD limit of detection.

It may be possible to make some assessment of the percentage of the total mass of the botanical that was detected by the CAD (assumed here to be 100%). It is possible that some measurable amount of material is lost due to volatility (under-represented or not detected by the CAD) or is not eluted (retained permanently or beyond the experiment duration) from the column. More remains to be learned about the broad chromatographic hump seen in some botanical analyses, such as this one, with respect to its relevance to the safety assessment.

In all probability, the most significant variables impacting overall effort, using this approach to characterize other botanicals, will be (1) the number of analytes present, (2) what is already known about that botanical and reported in the literature, and (3) what chromatography (and chromatographic method development) will be required.

Botanical safety and quality assessments {#Sec13}
----------------------------------------

Botanical extracts are complex mixtures of various chemical constituents and as such the chemical constituent identification approach has potential for application to the safety and quality assessment of botanicals. The U.S. Cosmetic Ingredient Review (CIR) considered safety data on chemical constituents in their favorable assessment of *Calendula officinalis* extracts \[[@CR19]\]. Monitoring of marker chemical constituents is often used for quality assessment of botanical extracts. The analytical techniques presented in this paper have been used for safety assessments of other botanicals and these results, from a toxicology perspective, have been reported \[[@CR17]\]. That paper discusses the relationships between dose and threshold of toxicological concern with quantitation of analytes and limits of quantitation detailed here. We have begun to utilize this approach for identification and quantitation of extractable constituents from other materials, as they relate to safety assessments. This work will be the subject of future reports.
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